Sheikhi Vahid, Heidari Zahra
Department of Pediatric Nephrology, Zahedan University of Medical Sciences, Zahedan, Iran.
Department of Endocrinology and Metabolism, Zahedan University of Medical Sciences, Zahedan, Iran.
Adv Biomed Res. 2022 Dec 26;11:124. doi: 10.4103/abr.abr_15_21. eCollection 2022.
Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are recognized as two common health problems. Metabolic diseases, such as dyslipidemia, obesity, and hypertension are known risk factors for NAFLD. In addition to these risk factors, other risk factors have been recently suggested, such as thyroid dysfunction.
In this study, adult patients with T2DM were recruited. Various clinical and biochemical parameters including thyroid function tests, liver function tests, and liver sonography in all participants were assessed and compared between with and without NAFLD groups.
Data from 926 diabetic patients were analyzed; of which, 744 (80.3%) had fatty liver. The prevalence of subclinical hypothyroidism (SCH) in patients with NAFLD was 11.6% and in patients without NAFLD was 6.0% ( = 0.029). Furthermore, the prevalence of overt hypothyroidism was higher in diabetic patients with NAFLD (3.9% vs. 1.6%); this difference was not statistically significant. In univariate logistic regression analysis, hemoglobin A1c (odds ratio [OR]: 8.13); history of insulin consumption (OR: 5.35); duration of diabetes (OR: 2.20); family history of diabetes (OR: 2.85); history of antihypertensive drug use (OR: 2.14) as well as SCH (OR: 2.03) were significant variables for NAFLD. According to the multivariate logistic model, after eliminating the confounding effect of age, sex, and body mass index; the chance of developing NAFLD in patients with SCH was 2.32 times higher than patients without SCH ( = 0.014).
NAFLD is extremely common in patients with T2DM. The relationship between hypothyroidism and NAFLD is independent of other risk factors.
非酒精性脂肪性肝病(NAFLD)和2型糖尿病(T2DM)是公认的两个常见健康问题。代谢性疾病,如血脂异常、肥胖和高血压是已知的NAFLD危险因素。除了这些危险因素外,最近还提出了其他危险因素,如甲状腺功能障碍。
本研究招募了成年T2DM患者。评估了所有参与者的各种临床和生化参数,包括甲状腺功能测试、肝功能测试和肝脏超声检查,并在有和没有NAFLD的组之间进行比较。
分析了926例糖尿病患者的数据;其中,744例(80.3%)患有脂肪肝。NAFLD患者亚临床甲状腺功能减退(SCH)的患病率为11.6%,无NAFLD患者的患病率为6.0%(P = 0.029)。此外,显性甲状腺功能减退在患有NAFLD的糖尿病患者中的患病率更高(3.9%对1.6%);这种差异无统计学意义。在单因素逻辑回归分析中,糖化血红蛋白(比值比[OR]:8.13);胰岛素使用史(OR:5.35);糖尿病病程(OR:2.20);糖尿病家族史(OR:2.85);抗高血压药物使用史(OR:2.14)以及SCH(OR:2.03)是NAFLD的显著变量。根据多因素逻辑模型,在消除年龄、性别和体重指数的混杂效应后;患有SCH的患者发生NAFLD的几率比没有SCH的患者高2.32倍(P = 0.014)。
NAFLD在T2DM患者中极为常见。甲状腺功能减退与NAFLD之间的关系独立于其他危险因素。